GLP-1 Weight Loss in Newport Beach

The arrival of GLP-1 receptor agonists has fundamentally reshaped what is achievable in non-surgical weight management. For patients in Newport Beach, CA, this means access to medications that produce 15 to 22 percent body weight reductions. A decade ago, those numbers were associated only with bariatric procedures. Dr. Adonis Saremi delivers physician-supervised GLP-1 therapy with the clinical thoroughness it demands: matching each patient to the right agent, managing titration personally, and supporting results with a complete metabolic health program.

What Are GLP-1 Receptor Agonists?

GLP-1 receptor agonists mimic glucagon-like peptide-1, a gut-derived hormone that regulates appetite, insulin secretion, and gastric motility. Activating GLP-1 receptors across the brain, pancreas, and GI tract produces sustained appetite suppression, improved blood sugar control, and meaningful reductions in body weight. Key agents include semaglutide (Ozempic, Wegovy), liraglutide (Saxenda), and the dual agonist tirzepatide (Mounjaro, Zepbound).

How GLP-1 Therapy Drives Weight Loss

• Hypothalamic appetite suppression. Reduces hunger signaling at the brain level, lowering overall food drive
• Extended post-meal satiety. Delayed gastric emptying prolongs fullness, reducing total caloric intake naturally
• Glucose regulation. Stabilized post-meal insulin responses reduce fat deposition
• Craving reduction. Meaningful decreases in food-seeking behavior, particularly for energy-dense foods
• Cardiometabolic benefits. Reduced blood pressure, improved lipid profiles, decreased waist circumference

Who Is Our GLP-1 Program in Newport Beach Designed For?

• Patients in Newport Beach who want a GLP-1 prescription managed by a board-certified Obesity Medicine specialist with real clinical oversight
• Adults with a BMI of 27-plus with a weight-related condition, or 30-plus, who are clinically appropriate candidates for incretin-based therapy
• Individuals who have not achieved goals through sustained diet and exercise and are ready for pharmacological support
• Patients with pre-diabetes, metabolic syndrome, or PCOS who benefit from both the metabolic and weight-management effects of GLP-1 therapy
• Results-driven Newport Beach residents who want a physician reachable via telemedicine or at their front door throughout treatment.

Physician Decision-Making at Every Step

Every GLP-1 prescription at our Newport Beach practice is a deliberate clinical decision, not an automated approval. This distinction determines the safety, appropriateness, and long-term outcome of your treatment.

Start your GLP-1 weight loss program in Newport Beach. Call (619) 736-1748 or schedule your consultation online today.

Frequently Asked Questions

Which GLP-1 medication produces the most weight loss?

Tirzepatide (Zepbound/Mounjaro) averages 20 to 22 percent weight loss at the highest dose in SURMOUNT trials. Semaglutide (Wegovy) averages approximately 15 percent. The right choice depends on your individual health profile.

What side effects should I expect?

Nausea, diarrhea, and constipation are most common during initial titration. These typically improve with continued use. Your physician helps manage tolerability proactively throughout treatment.